G1 Therapeutics Inc (GTHX)
4.27
-0.22
(-4.90%)
USD |
NASDAQ |
May 06, 16:00
4.275
0.00 (0.00%)
After-Hours: 20:00
G1 Therapeutics Total Assets (Quarterly): 102.03M for March 31, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 102.03M |
| December 31, 2023 | 121.54M |
| September 30, 2023 | 133.10M |
| June 30, 2023 | 147.89M |
| March 31, 2023 | 161.96M |
| December 31, 2022 | 187.96M |
| September 30, 2022 | 166.57M |
| June 30, 2022 | 186.88M |
| March 31, 2022 | 218.24M |
| December 31, 2021 | 254.09M |
| September 30, 2021 | 243.50M |
| June 30, 2021 | 276.76M |
| March 31, 2021 | 308.56M |
| December 31, 2020 | 228.55M |
| September 30, 2020 | 258.23M |
| Date | Value |
|---|---|
| June 30, 2020 | 253.60M |
| March 31, 2020 | 256.51M |
| December 31, 2019 | 284.83M |
| September 30, 2019 | 317.19M |
| June 30, 2019 | 331.65M |
| March 31, 2019 | 351.68M |
| December 31, 2018 | 371.27M |
| September 30, 2018 | 393.02M |
| June 30, 2018 | 190.60M |
| March 31, 2018 | 195.74M |
| December 31, 2017 | 105.17M |
| September 30, 2017 | 119.55M |
| June 30, 2017 | 134.10M |
| March 31, 2017 | 39.29M |
| December 31, 2016 | 48.21M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
102.03M
Minimum
Mar 2024
331.65M
Maximum
Jun 2019
221.98M
Average
236.02M
Median
Total Assets (Quarterly) Benchmarks
| Amicus Therapeutics Inc | 777.88M |
| Geron Corp | 482.07M |
| Palatin Technologies Inc | 13.55M |
| Oragenics Inc | 4.966M |
| TG Therapeutics Inc | 373.32M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 74.29M |
| Shareholders Equity (Quarterly) | 27.74M |
| Debt to Equity Ratio | 1.554 |
| Current Ratio | 2.940 |
| Net Debt Paydown Yield | 3.01% |